Login
Home
Charts
Search
Watchlist
Products

Mahamaya Lifesciences Ltd

MAHALIFE·BSE
₹182.50-2.56%Tue, 22 Sept '26 13:17
Industry:Pesticides/Agrochemicals
Indices:

Mahamaya Lifesciences Ltd

MAHALIFE
BSE
₹182.50
-2.56%
|Tue, 22 Sept '26 13:17
SOICxStockScans Reports
Industry
Pesticides/Agrochemicals
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹427Cr
Close
Close Price
₹182.50
Industry
Industry
Pesticides/Agrochemicals
PE
Price To Earnings
49.06
PS
Price To Sales
1.30
Revenue
Revenue
₹329Cr
Rev Gr TTM
Revenue Growth TTM
24.66%
PAT Gr TTM
PAT Growth TTM
28.86%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
146118163166
Growth YoY
Revenue Growth YoY%
11.540.6
Expenses
ExpensesCr
133108148149
Operating Profit
Operating ProfitCr
13101517
OPM
OPM%
9.18.19.310.4
Other Income
Other IncomeCr
1111
Interest Expense
Interest ExpenseCr
4344
Depreciation
DepreciationCr
1111
PBT
PBTCr
1181314
Tax
TaxCr
3234
PAT
PATCr
7688
Growth YoY
PAT Growth YoY%
15.446.3
NPM
NPM%
5.04.75.14.9
EPS
EPS₹
0.00.00.03.7
QuarterSep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
146118163166
Growth YoY
Revenue Growth YoY%
11.540.6
Expenses
ExpensesCr
133108148149
Operating Profit
Operating ProfitCr
13101517
OPM
OPM%
9.18.19.310.4
Other Income
Other IncomeCr
1111
Interest Expense
Interest ExpenseCr
4344
Depreciation
DepreciationCr
1111
PBT
PBTCr
1181314
Tax
TaxCr
3234
PAT
PATCr
7688
Growth YoY
PAT Growth YoY%
15.446.3
NPM
NPM%
5.04.75.14.9
EPS
EPS₹
0.00.00.03.7

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
90137162264329
Growth
Revenue Growth%
52.517.963.524.7
Expenses
ExpensesCr
84128148241296
Operating Profit
Operating ProfitCr
69132334
OPM
OPM%
6.86.58.28.710.2
Other Income
Other IncomeCr
00131
Interest Expense
Interest ExpenseCr
23678
Depreciation
DepreciationCr
11122
PBT
PBTCr
4571724
Tax
TaxCr
11247
PAT
PATCr
3451317
Growth
PAT Growth%
37.739.1148.027.6
NPM
NPM%
3.02.73.24.95.0
EPS
EPS₹
21.830.041.87.68.3
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
90137162264329
Growth
Revenue Growth%
52.517.963.524.7
Expenses
ExpensesCr
84128148241296
Operating Profit
Operating ProfitCr
69132334
OPM
OPM%
6.86.58.28.710.2
Other Income
Other IncomeCr
00131
Interest Expense
Interest ExpenseCr
23678
Depreciation
DepreciationCr
11122
PBT
PBTCr
4571724
Tax
TaxCr
11247
PAT
PATCr
3451317
Growth
PAT Growth%
37.739.1148.027.6
NPM
NPM%
3.02.73.24.95.0
EPS
EPS₹
21.830.041.87.68.3

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025
Equity Capital
Equity CapitalCr
11118
Reserves
ReservesCr
14182332
Current Liabilities
Current LiabilitiesCr
304878132
Non Current Liabilities
Non Current LiabilitiesCr
101197
Total Liabilities
Total LiabilitiesCr
5678112188
Current Assets
Current AssetsCr
335487157
Non Current Assets
Non Current AssetsCr
22242532
Total Assets
Total AssetsCr
5678112188
Financial YearMar 2022Mar 2023Mar 2024Mar 2025
Equity Capital
Equity CapitalCr
11118
Reserves
ReservesCr
14182332
Current Liabilities
Current LiabilitiesCr
304878132
Non Current Liabilities
Non Current LiabilitiesCr
101197
Total Liabilities
Total LiabilitiesCr
5678112188
Current Assets
Current AssetsCr
335487157
Non Current Assets
Non Current AssetsCr
22242532
Total Assets
Total AssetsCr
5678112188

Cash Flow

Consolidated
Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
21-231-30
Investing Cash Flow
Investing Cash FlowCr
-3-3-2-8-16
Financing Cash Flow
Financing Cash FlowCr
1224981
Net Cash Flow
Net Cash FlowCr
010135
Free Cash Flow
Free Cash FlowCr
-1-2-25-8
CFO To PAT
CFO To PAT%
79.430.0-432.54.0-178.7
CFO To EBITDA
CFO To EBITDA%
35.612.6-170.42.3-88.1
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
21-231-30
Investing Cash Flow
Investing Cash FlowCr
-3-3-2-8-16
Financing Cash Flow
Financing Cash FlowCr
1224981
Net Cash Flow
Net Cash FlowCr
010135
Free Cash Flow
Free Cash FlowCr
-1-2-25-8
CFO To PAT
CFO To PAT%
79.430.0-432.54.0-178.7
CFO To EBITDA
CFO To EBITDA%
35.612.6-170.42.3-88.1

Ratios

Consolidated
Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
352427
Price To Earnings
Price To Earnings
21.349.1
Price To Sales
Price To Sales
1.11.3
Price To Book
Price To Book
2.93.5
EV To EBITDA
EV To EBITDA
14.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
16.013.613.814.1
OPM
OPM%
6.86.58.28.710.210.2
NPM
NPM%
3.02.73.24.95.05.0
ROCE
ROCE%
15.318.116.422.5
ROE
ROE%
17.319.321.226.2
ROA
ROA%
4.94.84.76.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
352427
Price To Earnings
Price To Earnings
21.349.1
Price To Sales
Price To Sales
1.11.3
Price To Book
Price To Book
2.93.5
EV To EBITDA
EV To EBITDA
14.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
16.013.613.814.1
OPM
OPM%
6.86.58.28.710.210.2
NPM
NPM%
3.02.73.24.95.05.0
ROCE
ROCE%
15.318.116.422.5
ROE
ROE%
17.319.321.226.2
ROA
ROA%
4.94.84.76.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Mahamaya Lifesciences Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/as-8d8a32ad83fd5b98abb091dd.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/vfxmf6pfknelpd0zdfm202xz.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/s6dei7p35mg71cn9l2gy9ura.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/ssjbf4mpir6o9o3dve1mcq2e.pdf

Concall Transcript Summaries — Mahamaya Lifesciences Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/BSE%3AMAHALIFE/transcript-notes/202606/as-8d8a32ad83fd5b98abb091dd.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies